Safety and Efficacy of Ubrogepant in Participants With Moderate to High Cardiovascular Risk

被引：0
|
作者：
Severt, Lawrence [1 ]
Silberstein, Stephen D. [2 ]
Blumenfeld, Andrew M. [3 ]
Lipton, Richard B. [4 ]
Lu, Kaifeng [1 ]
Yu, Sung Yun [1 ]
Hutchinson, Susan [5 ]
机构：
[1] Allergan Plc, Dublin, Ireland
[2] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[3] Headache Ctr Southern Calif, Irvine, CA USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Orange Cty Migraine & Headache Ctr, Irvine, CA USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
107
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Safety of Ubrogepant in Participants with Moderate to High Cardiovascular Risk
    Hutchinson, S.
    Silberstein, S. D.
    Blumenfeld, A. M.
    Lipton, R. B.
    Lu, K.
    Yu, S.
    Severt, L.
    HEADACHE, 2019, 59 : 104 - 105
  • [2] Safety of Ubrogepant in Participants With Moderate to High Cardiovascular Risk
    Hutchinson, Susan
    Silberstein, Stephen D.
    Blumenfeld, Andrew M.
    Lipton, Richard B.
    Lu, Kaifeng
    Yu, Sung Yun
    Severt, Lawrence
    CEPHALALGIA, 2019, 39 : 196 - 197
  • [3] Efficacy and Safety of Ubrogepant in Participants Taking Concomitant Preventive Medication
    Blumenfeld, Andrew M.
    Knievel, Kerry
    Adams, Aubrey Manack
    Severt, Lawrence
    Butler, Matthew
    Lai, Hongxin
    Dodick, David W.
    NEUROLOGY, 2020, 94 (15)
  • [4] EFFICACY AND SAFETY OF UBROGEPANT IN PARTICIPANTS TAKING CONCOMITANT PREVENTIVE MEDICATION
    Blumenfeld, Andrew M.
    Knievel, Kerry
    Adams, Aubrey Manack
    Severt, Lawrence
    Butler, Matthew
    Lai, Hongxin
    Dodick, David W.
    CEPHALALGIA, 2020, 40 : 47 - 48
  • [5] Efficacy and Safety of Ubrogepant in Participants Taking Concomitant Preventive Medication
    Blumenfeld, A. M.
    Knievel, K.
    Adams, Manack A.
    Severt, L.
    Butler, M.
    Lai, H.
    Dodick, D. W.
    HEADACHE, 2020, 60 : 92 - 93
  • [6] Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II
    Hutchinson, Susan
    Silberstein, Stephen D.
    Blumenfeld, Andrew M.
    Lipton, Richard B.
    Lu, Kaifeng
    Yu, Sung Yun
    Severt, Lawrence
    CEPHALALGIA, 2021, 41 (09) : 979 - 990
  • [7] Efficacy and safety of irbesartan/hydrochlorothiazide as initial therapy in subgroups of patients with moderate to severe hypertension at high cardiovascular risk
    Neutel, J.
    Bhaumik, A.
    Ptaszynska, A.
    Franklin, S.
    LaPuerta, P.
    JOURNAL OF HYPERTENSION, 2007, 25 : S112 - S113
  • [8] Real World Efficacy, Tolerability and Safety of Ubrogepant
    Chiang, Chia-Chun
    Arca, Karissa
    Dunn, Rachel
    Girardo, Marlene
    Quillen, Jaxon
    Dodick, David
    Starling, Amaal
    NEUROLOGY, 2021, 96 (15)
  • [9] Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
    Ridker, P. M.
    Revkin, J.
    Amarenco, P.
    Brunell, R.
    Curto, M.
    Civeira, F.
    Flather, M.
    Glynn, R. J.
    Gregoire, J.
    Jukema, J. W.
    Karpov, Y.
    Kastelein, J. J. P.
    Koenig, W.
    Lorenzatti, A.
    Manga, P.
    Masiukiewicz, U.
    Miller, M.
    Mosterd, A.
    Murin, J.
    Nicolau, J. C.
    Nissen, S.
    Ponikowski, P.
    Santos, R. D.
    Schwartz, P. F.
    Soran, H.
    White, H.
    Wright, R. S.
    Vrablik, M.
    Yunis, C.
    Shear, C. L.
    Tardif, J. -C.
    Conde, Diego
    Colquhoun, David
    Missault, Luc
    Gregoire, Jean
    Gao, Runlin
    Urina, Miguel
    Solar, Miroslav
    Jensen, Henrik Kjaerulf
    Grobbee, Diederick
    Savolainen, Markku
    Schiele, Francois
    Montalescot, Gilles
    Edes, Istvan
    Blake, Gavin
    Lotan, Chaim
    Maggioni, Aldo
    Savonitto, Stefano
    Lee, Cheol Whan
    Leiva Pons, Jose Luis
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1527 - 1539
  • [10] Real world efficacy, tolerability and safety of ubrogepant
    Chiang, C.
    Arca, K. N.
    Dunn, R. B.
    Girardo, M. E.
    Quillen, J. K.
    Dodick, D. W.
    Starling, A. J.
    HEADACHE, 2021, 61 : 139 - 140
12345